FAP, May 30 / PRNewswire-FirstCall-Asianet /-- Pril Pharmaceutical announced that it recently received a listing license for trimebutine maleate tablets issued by Health Canada. The drug is mainly used in the treatment of gastrointestinal dysfunction and irritable bowel syndrome.